Hidradenitis Suppurativa (HS) Clinical Study Details
Struggling with moderate to severe HS? Join our clinical trial exploring an investigational treatment: expert care, no-cost participation, and a chance to take part in clinical research.
Apply To This Study Here
Please enter your name, a valid phone number, and a valid email address where you can be contacted.
Yes, if you’re between 18 and 80 years old.
Yes, you must have been diagnosed with Hidradenitis Suppurativa (HS) by a dermatologist and had symptoms for at least 6 months.
To qualify, you need to have at least 6 active inflammatory HS lesions for 8 weeks or more and affected areas in at least two different parts of your body. At least one area must be moderate to severe (Hurley Stage II or III).
Yes. All participants must follow strict birth control guidelines during the study and for 90 days after their last dose, whether male or female. This includes using approved contraceptive methods.
No. You must agree not to become pregnant, donate sperm, or plan for pregnancy during the study and for 90 days after it ends.
You must give written informed consent, attend all study visits, and follow all study-related procedures and instructions.
Benefits of participating in this study
There are multiple ways you can benefit from joining us in this study. Here are some of them.
Study-related visits, evaluations, and close health monitoring are provided at no cost to participants.
Study visits include complimentary meals and transportation assistance for your appointment day.
Your participation helps researchers better understand medical conditions in a way that may benefit others, including friends, family, and future generations.